Skip to main content

Table 4 Non-haematological toxicity

From: A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients

Worst toxicity severity grade of non-haematological toxicity by patient (number of patients (%))
Toxicity severity grade 2 3 4
Fatigue 10 (38) 2 (8)  
Abdominal pain 4 (15) 2 (8)  
Constipation 7 (27)   
Nausea 5 (19) 2 (8)  
Back pain 3 (12) 2 (8)  
Oedema peripheral 5 (19)   
Vomiting 3 (12) 2 (8)